Insulet Expands Omnipod Discover Platform Nationwide

Event summary

Insulet launched the full U.S. market release of Omnipod Discover, a web-based data platform for Omnipod 5 users and healthcare providers.
The platform has already been adopted by 15,000 U.S. users and 1,800 healthcare professionals during a limited market release.
Omnipod Discover provides personalized glucose and insulin delivery reports, aiming to improve diabetes management decisions.
Real-world data presented at the American Diabetes Association’s Scientific Sessions showed a 32% increase in time in range for some users.

The big picture

Insulet’s expansion of Omnipod Discover aligns with the broader trend toward data-driven diabetes management, where platforms that simplify complex health data gain traction. The platform’s integration with Omnipod 5 positions Insulet to compete more effectively in the automated insulin delivery market, where real-world outcomes and user engagement are key differentiators.

What we're watching

Adoption Pace: Whether the nationwide rollout will accelerate user and healthcare provider adoption beyond the initial 15,000 users.
Clinical Impact: How sustained engagement with Omnipod Discover will affect long-term glycemic outcomes for users.
Competitive Positioning: The extent to which Omnipod Discover differentiates Insulet from competitors in the automated insulin delivery space.